Hefei Lifeon Pharmaceutical Co., Ltd.

¥15.20As of Sun 8 Nov 2026, 12:00 UTC
SZSE:003020Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 3.04%
Div yield 2.74%
ROE 7.29%
Biotechnology
Beta (5Y) (0.04)
PE TTM 22.81
TSR TTM (34.38%)
Mkt cap ¥3.469B
ROIC 8.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
27.25%
(25.86%)
Hold 11|11|1|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.21
0.23
0.26
4.77%
(4.94%)
7.37%
15.12%
Revenue¥M
501.0
526.9
531.1
553.6
13.21%
18.61%
13.13%
15.65%
Peers (US$520.0M)
Cap (US$)
PE
526.1M
63.33x
513.5M
263.7x
Capital
TTM
5Y
10Y
Leveragex
2.098
0.109
0.106
EBIT/Intx
1.300
1.046
0.792
Own earn%
276.34
14.72
11.02
Sh yield%
35.33
26.43
26.72
Owners
Insiders/Inst%
9.68
83.24
Short interest%
3.79
SBC / revenue%
5.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
9